ROLE OF LOCOREGIONAL TREATMENT IN THE MANAGEMENT OF METASTATIC BREAST CANCER
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 1
Abstract
BACKGROUND The treatment of metastatic breast cancer depends on the individual patient and receptor status and general condition of the patient. Even with newer systemic and locoregional treatment, metastatic breast cancer cannot be cured completely at present. In few patients with good prognostic factor, these treatment modalities increase the progression-free survival which in turn may significantly affect the overall survival. Many patients with metastases may live several years with modern locoregional treatment and systemic chemotherapy. The aim of the treatment of metastatic breast cancer should be towards increasing the symptom-free survival and quality of life. At the same time the side effects of the treatment should be minimised. The objective of the study is to evaluate the role of locoregional treatment such as local radiotherapy and surgery in the management of patients with metastatic breast cancer. MATERIALS AND METHODS This is a retrospective observational study. One hundred and Ninety-five patients with metastatic breast cancer between the years 2003 to 2008 were taken for this retrospective ongoing study. Among these, seventy-five patients did not receive locoregional treatment, and the remaining one hundred and twenty patients received locoregional treatment to the primary. Locoregional treatment included radiotherapy and surgery. RESULTS Patient’s survival was analysed at the end of 1 year, 3 years, 5 years, and at the end of 10 years. It was found that, in patients receiving concurrent chemoirradiation, survival rates at the end of 1, 3, 5 and 10 years were 89%, 58%, 46% and 42% respectively. Similarly, in patients receiving concurrent chemoirradiation followed by surgery, survival was 97%, 80%, 71% and 70% respectively. Further, survival for chemotherapy was 60%, 5%, 2% and 0% respectively. Again, for the arm including only radiotherapy, survival was around 67%, 33%, 33% and 33% respectively. Those patients who receive only hormonal therapy had 50%, 13%, 13% and 13% overall survival at the end of 1, 3, 5 and 10 years. CONCLUSION The data reported in this retrospective study confirmed that chemoirradiation improved overall survival and symptomatic local control, demonstrated in locoregionally treated patients with metastatic breast cancer.
Authors and Affiliations
Sivagnanam Balaji, Sam Deva Kumar J, Selvaluxmy G
ADENOID CYSTIC CARCINOMA OF PARANASAL SINUS – A RARE CONDITION
Adenoid cystic carcinoma of the paranasal sinuses is not a very common condition. It tends to arise from the maxillary antrum and can infiltrate into the surrounding tissue. They demonstrate perineural invasion...
TO EVALUATE THE COMPARISON OF INTUBATING CONDITIONS USING FENTANYL PLUS PROPOFOL VERSUS NALBUPHINE PLUS PROPOFOL DURING FIBEROPTIC INTUBATION
BACKGROUND Awake nasal or oral flexible fiberoptic intubation (AFOI) is the airway management technique of choice in known or anticipated difficult airway, severe cervical stenosis, Chiari malformation, unstable cervical...
ISOLATED TESTICULAR TUBERCULOSIS: A DUBIOUS FACADE
BACKGROUND Isolated testicular tuberculosis is a bizarre entity and it can present with atypical clinical features and its radiological signs remain elusive. Owing to its unusual occurrence and presentation, it...
A RETROSPECTIVE STUDY ON PLACENTAL IMPLANTATION SITE AND MATERNAL AND FOETAL OUTCOME IN PRIMIGRAVIDA
[b]OBJECTIVE[/b]: To determine the Gestational Age at the onset of labour, the birth weight of the neonate and the mode of delivery in anterior and posterior placentation. [b]STUDY DESIGN: [/b]This is a retros...
ADULT ONSET STILL’S DISEASE
Adult onset Still’s disease is an uncommon autoimmune inflammatory disease, most often seen in young adults. It presents as a combination of systemic manifestations typically including spiking fevers, short – l...